Company Filing History:
Years Active: 2015
Title: Knud J Jensen: Innovator in Diabetes Treatment
Introduction
Knud J Jensen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of diabetes treatment through his innovative work on human insulin analogues. His research and inventions have the potential to improve the lives of many individuals living with diabetes.
Latest Patents
Knud J Jensen holds 1 patent for his invention titled "Human insulin analogues and derivatives comprising cysteine substitutions." This patent relates to human insulin analogues that contain a substituting cysteine, as well as human insulin derivatives that include a PEGylated substituting cysteine. The compounds developed through this invention may be useful for the treatment of diabetes, showcasing Jensen's commitment to advancing medical science.
Career Highlights
Jensen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development in diabetes treatment.
Collaborations
Some of Jensen's notable coworkers include Tine Nygaard Vinther and Thomas Boerglum Kjeldsen. Their collaborative efforts have further enhanced the research and development initiatives at Novo Nordisk, leading to innovative solutions for diabetes management.
Conclusion
Knud J Jensen's contributions to the field of diabetes treatment through his patented inventions highlight his role as an important innovator. His work continues to pave the way for advancements in medical science, particularly in the management of diabetes.